Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 427-370-1 | CAS number: 164288-56-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline, GLP study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- -
- EC Number:
- 427-370-1
- EC Name:
- -
- Cas Number:
- 164288-56-6
- Molecular formula:
- C21H44N3O3Cl
- IUPAC Name:
- {[(2-hydroxyethyl)carbamoyl]methyl}dimethyl(3-octadecanamidopropyl)azanium chloride
- Reference substance name:
- Sodium chloride
- EC Number:
- 231-598-3
- EC Name:
- Sodium chloride
- Cas Number:
- 7647-14-5
- Molecular formula:
- ClNa
- IUPAC Name:
- sodium chloride
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- Water
Constituent 1
impurity 1
impurity 2
- Specific details on test material used for the study:
- Purity: 94%
Lot number: 1514MP
Description: orange solid gel
Storage conditions: room temperature in the dark
Method
Species / strain
- Species / strain / cell type:
- lymphocytes:
- Details on mammalian cell type (if applicable):
- For each experiment, sufficient whole blood was drawn from the peripheral circulation of a volunteer who had been previously screened for suitability. The volunteer had not been exposed to high levels of radiation or hazardous chemicals and had not knowingly recently suffered from a viral infection. The ceIl-cycle time for the lymphocytes from the donor used in this study was determined using BrdU (bromodeoxyuridine) incorporation to assess the number of first, second and third division metaphase cells and so calculate the average generation time (AGT). The average AGT for the regular donors used in this laboratory has been determined to be approximately 14 hours under optimal growth conditions.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Lot No. Aro. S9/22/08/98 was prepared, in-house, from the livers of male Sprague-Dawley rats weighing 250g. These had received a single injection of Aroclor 1254 at 500 mg/kg, five days before S9 preparation.
- Test concentrations with justification for top dose:
- Experiment 1
Final concentration of the test item (ug/mL)
(4) 16h -S9 0, 39.07, 78.13, 156.25, 312.5, 625, 1250, 2500, 5000, EMS 750
(4) 16h +S9 0, 39.07, 78.13, 156.25, 312.5, 625, 1250, 2500, 5000, CP 25
EMS: Ethyl methanesulphonate
CP: Cyclophosphamide
Experiment 2
Final concentration of the test item (pg/ml)
20h -S9 0, 2.44, 4.88, 9.77, 19.54, 39.07, 78.13, 156.25, 312.5, EMS 500
(4) 16h +S9 0, 4.88, 9.77, 19.54, 39.07, 78.13, 156.25, 312.5, 625, CP 25
Controlsopen allclose all
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- CelI Culture
CeIls were grown in Eagle’s minimal essential media, (supplemented with sodium bicarbonate, HEPES buffer, L-glutamine, pen iciIin/streptomycin, amphotericin B and 15% foetal calf serum) at 37 °C with 5% CO2 in air. The lymphocytes of fresh heparinised whole blood were stimulated to divide by the addition of phytohaemagglutinin (PHA) at 90 ug/mL final concentration.
The test material was accurately weighed, dissolved in Minimal Essential Media (MEM) and serial two-fold dilutions prepared. The maximum dose level tested was 5000 ug/mL which was the maximum recommended dose level. There was no observable change in pH when the test material was dosed into media and the osmolality did not increase by more than 50 mOSM. Chemical analysis of the test material formulations was not performed because it is not a requirement of the test method.
Culture Conditions - Experiment 1
Duplicate lymphocyte cultures (A and B) were established for each dose level by mixing the following components, giving, when dispensed into sterile plastic flasks for each culture:
8.05 to 9.05 ml MEM, 15% (FCS)
0.1 ml Li-heparin
0.1 ml phytohaemagglutinin
0.75 ml heparinised whole blood
Treatment With-activation:
After approximately 48 hours incubation at 37°C, 5% C02 in humidified air, the with-S9 cultures were centrifuged after transfer into tubes and approximately 9 ml of the culture medium removed, reserved and replaced with MEM (including serum) and 0.1 ml of the appropriate solution of positive control or 1 ml of appropriate solution of vehicle or test material was added to each culture. The final concentrations of the test material were 39.07, 78.13, 156.25, 312.5, 625, 1250, 2500 and 5000 ug/ml. 1 ml of 10% S9 (je 1 % final concentration of S9) in standard co-factors was added and the cultures returned to the incubator.
After 4 hours at 37 °C the with-S9 cultures were centrifuged, the treatment medium removed by suction and replaced with an 8 ml wash of MEM culture medium. After a further centrifugation the wash medium was removed by suction and replaced with the original culture medium. The cells were then re-incubated for a further 16 hours.
Treatment Without-activation:
After approximately 48 hours incubation at 37°C, 5% C02 in humidified air the cultures were decanted into centrifuge tubes and centrifuged, as for the treatment with-activation. Most of the culture media was drawn off and stored. The cells were then resuspended with fresh MEM (including serum).
The total volume for each culture was a nominal 9.9 ml for non-aqueous vehicles and 9.0 mIs for aqueous vehicles. The final concentrations were the same as for the with-activation treatments.
Culture Conditions - Experiment 2
These were as in previous section, except that there was continuous exposure in the absence of metabolic activation. The exposure in the presence of activation was for 4 hours, followed by a 16-hour expression period as performed in Experiment 1. The final concentration of S9 was increased, 1 ml of 20% S9 (ie 2% final concentration) in standard co-factors was added and the cultures returned to the incubator. The final concentrations of the test material were 2.44, 4.88, 9.77, 19.54, 39.07, 78.13, 156.25, 312.5 and 625 ug/ml. - Evaluation criteria:
- Where possible the first 100 consecutive well-spread metaphases from each culture were counted, and if the cell had 44-48 chromosomes, any gaps, breaks or rearrangements were noted according to the simplified system of Savage (1976) recommended in the 1983 UKEMS guidelines for mutagenicity testing. CeIls with chromosome aberrations were reviewed as necessary by a senior cytogeneticist prior to decoding the slides.
- Statistics:
- The frequency of cells with aberrations (both including and excluding gaps) and the frequency of polyploid cells was compared, where necessary, with the concurrent vehicle control value using Fisher’s Exact test.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no mutagenic potential (based on QSAR/QSPR prediction)
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
The test material did not induce a statistically significant increase in the frequency of cells with chromosome aberrations (excluding gaps) in either the presence or absence of a liver enzyme metabolising system in either of two separate experiments. The test item was therefore considered to be non-clastogenic to human lymphocytes in vitro. - Executive summary:
Duplicate cultures of human lymphocytes, treated with the test material, were evaluated for chromosome aberrations at up to four dose levels, together with vehicle and positive controls. Four treatment conditions were used for the study, ie. 4 hours exposure with the addition of an induced rat liver homogenate metabolising system (S9) with cell harvest after a 16-hour expression period and a 4-hour exposure in the absence of activation with a 16-hour expression period, this was Experiment 1. In Experiment 2 the 4-hour exposure with addition of S9 was repeated (using 2% final S9 concentration), whilst in the absence of activation the exposure time was increased to 20 hours.
The method used followed that described in the OECD Guidelines for the Testing of Chemicals (1997) No. 473 “Genetic Toxicology: Chromosome Aberration Test” and Method B10 of Commission Directive 92/69/EEC.
Cytotoxicity was observed with the tested concentrations.
All vehicle (solvent) controls gave frequencies of cells with aberrations within the range expected for normal human lymphocytes.
AIl the positive control treatments gave statistically significant increases in the frequency of cells with aberrations indicating the satisfactory performance of the test and of the activity of the metabolising system.
The test material did not induce any statistically significant increases in the frequency of cells with aberrations in either of two separate experiments. The test material was shown to be non-clastogenic to human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.